Abstract | To ensure its duplication, chromosomal DNA must be precisely duplicated in each cell cycle, with no sections left unreplicated, and no sections replicated more than once. Eukaryotic cells achieve this by dividing replication into two non-overlapping phases. During late mitosis and G1, replication origins are 'licensed' for replication by loading the minichromosome maintenance (Mcm) 2-7 proteins to form a pre-replicative complex. Mcm2-7 proteins are then essential for initiating and elongating replication forks during S phase. Recent data have provided biochemical and structural insight into the process of replication licensing and the mechanisms that regulate it during the cell cycle.
For the cell division cycle to produce two daughter cells that inherit a perfect copy of the genetic material that is originally present in the mother cell, it must accomplish two complex tasks: the chromosomal DNA must first be precisely replicated, with no errors, deletions or duplications, and then the two copies must be precisely segregated into the two daughter cells. The accuracy of these events is crucial to multicellular organisms, in which any changes to the genome potentially give rise to cancers that threaten the life of the entire organism. This review concentrates on the first of these linked problems: how eukaryotic cells ensure that their chromosomal DNA is precisely duplicated during the S phase of the cell cycle.
A large number of replication origins (typically ~10 3 -10 5 ) BOX 1 are used by eukaryotes to ensure that the entire genome is fully replicated. But these origins must be strictly regulated. How does the cell know whether it has already replicated a section of DNA in S phase? Eukaryotes have solved this problem by providing a marker to distinguish replicated from unreplicated DNA. The fact that replicated DNA differs from unreplicated DNA was first indicated by the classic cell-fusion experiments of Rao and Johnson 1 . In hybrids of G1 and G2 cells, the unreplicated G1 nucleus passes directly into S phase, whereas the DNA of the G2 nucleus (which has already been replicated) does not replicate again until after the hybrid cell has passed through mitosis. The G2 nucleus is therefore refractory to further DNA replication. Subsequent work that used cell-free extracts of Xenopus laevis eggs refined this idea and suggested a model whereby replication origins were 'licensed' for replication during late mitosis and G1, but the licence was removed as the DNA was replicated 2 . Dividing the process of DNA replication into two non-overlapping phases (one phase that is permissive for the licensing of DNA replication and a second phase that is permissive for the initiation of replication, but not for licensing) can potentially explain how cells ensure the precise duplication of chromosomal DNA in a single cell cycle.
Detailed experimental support for the licensing model has now been obtained, which indicates that it comprises four essential features 3, 4 . First, replication origins are licensed by stably binding complexes of the minichromosome maintenance 2-7 proteins (Mcm2, Mcm3, Mcm4, Mcm5, Mcm6 and Mcm7). Mcm2-7 proteins form an essential component of the prereplicative complex (pre-RC) of proteins that are found at replication origins during G1 phase. Second, the binding of Mcm2-7 proteins to origin DNA is essential for the origin to initiate a pair of replication forks. Third, the licensing of origins and the loading of Mcm2-7 onto DNA is restricted to late mitosis and G1 of the cell cycle. Fourth, Mcm2-7 proteins are displaced from origins as DNA replication is initiated, probably DNA HELICASE A class of enzyme that uses NTP hydrolysis to transiently separate double-stranded DNA into two single DNA strands. ATPase 
MOTIF
A group of conserved aminoacid sequences that are predicted to form a structure that can bind and hydrolyze ATP.
by travelling ahead of the replication fork. The licence is therefore never associated with replicated DNA.
These features can explain why DNA replicates only once in each cell cycle (FIG. 1) . Recent results also indicate that the presence or absence of licensed origins has broader implications for cell biology, as it might play a part in determining the proliferative capacity of cells 3 .
Understanding the function of Mcm2-7
The Mcm2-7 complex consists of six closely related proteins that are highly conserved throughout the eukaryotic kingdom (forming the MCM/P1 family). Each protein has a relatively highly conserved C terminus, which shows sequence homology to hexameric DNA In vitro, all six proteins are required for maximum ATPase activity, and the ATPase motifs of all six proteins are required for viability in Saccharomyces cerevisiae 7 . Chromatin immunoprecipitation experiments have revealed that the MCM proteins are associated with replication forks as they elongate along chromosomal DNA 8 , whereas inhibition of Mcm2-7 function during S phase causes a rapid cessation of DNA synthesis [9] [10] [11] , indicating that Mcm2-7 function is required for fork progression as well as initiation. These observations all indicate that Mcm2-7 functions as a helicase that unwinds DNA ahead of the replication fork. The Mcm2-7 helicase is therefore probably displaced from replicated DNA by moving ahead of the replication fork. The displacement of the replication licence from replicated DNA is one of the important features of the licensing factor model.
The Archaea possess proteins with high sequence homology to the eukaryotic MCM/P1 protein family. The single MCM protein from Methanobacter thermoautotrophicum forms dodecamers that display DNA helicase activity in vitro [12] [13] [14] . A crystal structure of the N terminus of this MCM complex has recently been reported 15 . This reveals a double hexameric structure, with a large positively charged channel running through the centre that is wide enough to surround double-stranded DNA (FIG. 2a-c) . The C-terminal helicase domain that is missing from the crystal structure could form an extra ring facing away from the dimer interface. This conclusion is supported by electron microscopy of the full-length archaeal MCM protein, which shows a bilobed hexameric structure with a large central channel 16 . Modelling indicated that the N-terminal domain fits into the central part of the structure, whereas the helicase-containing C terminus could form the extra lobe (FIG. 2d) .
This structure has interesting implications for the function of the eukaryotic Mcm2-7 proteins and their role in replication licensing. As can be seen from FIG. 1, it is crucial that the binding of Mcm2-7 to DNA is both stable and regulated. Mcm2-7 complexes that are loaded onto DNA in late mitosis must remain associated with DNA through G1 and into S phase. It is also crucial that once the licensing system is turned off in late G1, there is no illegitimate association of Mcm2-7 with DNA. These problems can be overcome if the loading of Mcm2-7 onto DNA is achieved by the Mcm2-7 hexamer encircling the DNA. This would lead to a stable association between Mcm2-7 and the DNA, which could be tightly controlled by regulating the activity of a 'loader' , which would be required to open the hexamer and clamp it around DNA. Therefore, the structure of M. thermoautotrophicum MCM provides an explanation for two of the fundamental features of the licensing model -the stability and temporal control of Mcm2-7 protein binding.
The structure of the MCM protein in M. thermoautotrophicum is highly congruent with the helicase domain of the SV40 large T antigen, the crystal structure of which has recently been determined 17 . T antigen is the replicative helicase for SV40 DNA. Similar to the M. thermoautotrophicum MCM, T antigen forms a bilobed double hexamer with a large central channel. Interestingly, T antigen contains exit channels through which single-stranded DNA might be extruded as the helicase progresses, and features consistent with this can be seen in M. thermoautotrophicum MCM 16 . Li et al. propose a mechanism by which T antigen unwinds DNA as it is replicated (FIG. 3) . T antigen encircles both strands of template DNA prior to initiation, which for Mcm2-7 would correspond to the licensed but uninitiated state. On initiation, one of the single strands is extruded through the side channels, while the other single strand exits the helicase at the hexamer-hexamer interface. This model is consistent with previous models based on the extruded 'rabbit ears' of single-stranded DNA that had been observed when T antigen interacts with origin DNA in vitro 18 .
The 'MCM paradox'
There are observations, however, that do not fit neatly into this model of Mcm2-7 functioning as a simple replication fork helicase. First, whereas one might have thought that only one double hexamer needs to be loaded onto each replication origin, the number in eukaryotes instead seems to be much higher, with 10-40 Mcm2-7 hexamers present at each origin [19] [20] [21] [22] . The loading of Mcm2-7 onto chromatin depends on the origin recognition complex (ORC), which is thought to bind specifically to replication origins. ORC recruits two further proteins, Cdc6 and Cdt1, which together facilitate the loading of Mcm2-7. However, studies in HeLa cells and X. laevis extracts indicate that Mcm2-7 is also loaded onto sites on the chromosome that are distant from ORC [22] [23] [24] [25] [26] . ATP hydrolysis by S. cerevisiae ORC is specifically required for loading the subsequent Mcm2-7 complexes after the first ones have been loaded onto DNA 27 , which provides further evidence that several copies of Mcm2-7 are loaded onto each origin. The distribution of Mcm2-7 on chromatin therefore does not match the expected distribution of a simple replicative helicase -which would be loaded at DNA replication origins and at only two copies per origin. A second discrepancy is that although some Mcm2-7 co-localizes with replication forks 8 , the bulk of the chromatin-bound protein is not associated with sites of DNA synthesis [28] [29] [30] . There are several possible explanations for this paradoxical distribution of Mcm2-7 on chromosomes. One possibility is that Mcm2-7 does not function as a typical DNA helicase, but instead functions as a fixed pump that forces DNA into immobilized replication forks where DNA synthesis occurs 31 . Because the DNA will be twisted as it is pumped, this will provide the energy to unwind the DNA ahead of the DNA polymerases, obviating the need for a helicase at the fork. However, for this to happen, the DNA between the Mcm2-7 pump and the DNA polymerases must be protected from TOPOISOMERASE-mediated relaxation, which would dissipate the stored energy and allow the DNA to rewind.
An alternative possibility is that, although a small fraction of Mcm2-7 is required to license and initiate the replication of DNA, the bulk of the Mcm2-7 is not involved in DNA synthesis, either having a different function 32, 33 or only being required for some contingency. Consistent with the idea that most of the Mcm2-7 is not usually involved in DNA synthesis is the observation that near-maximal replication rates can be achieved in X. laevis with only 1-2 heterohexamers of Mcm2-7 per replication origin 21, 22, 34 . Although X. laevis Cdc6 is required for the loading of Mcm2-7 onto DNA, its affinity for replication origins decreases once the first Mcm2-7 hexamers have been loaded onto each origin 34 . This plausibly ensures that under conditions where the extent of Mcm2-7 loading is limited, each origin gets the minimum allocation for it to support initiation. But what is the function of the excess Mcm2-7 hexamers? One proposal is that excess Mcm2-7 might activate INTRASPHASE CHECKPOINTS. Human MCM7 interacts with ATRIP, a protein that binds and activates the ATR kinase that is involved in checkpoint signalling when DNA replication is disturbed 35 . When MCM7 levels were slightly reduced so that replication rates were not significantly reduced, checkpoint signalling pathways were also disrupted 35 . The presence of excess Mcm2-7 at replication origins might explain a puzzling feature of eukaryotic replication origins, which in many circumstances form diffuse initiation sites that are not precisely specified by DNA sequence 36 . If the Mcm2-7 helicase has a similar mode of action to SV40 T antigen, then the site of assembly of a back-to-back Mcm2-7 dimer on DNA could potentially specify a replication origin. It is possible that the 10-40 Mcm2-7 hexamers that are loaded onto each origin form a number of back-toback dimers, each of which could provide a different site at which initiation could occur. This might provide redundant origins for use if various components of the replication machinery were to fail.
The licensing reaction
The loading of Mcm2-7 onto DNA that occurs as an origin is licensed probably involves the opening of the Mcm2-7 ring to allow it to encircle the DNA. Other protein components of the pre-RC are required to load Mcm2-7 onto chromatin. One of the first events is the binding of ORC to DNA (FIG. 4) . ORC, in turn, recruits two further proteins, Cdc6 and Cdt1, which are required for the loading of Mcm2-7 and the functional licensing of the origin 3, 4, 37 . This process has been reconstituted on X. laevis sperm chromatin using purified ORC, Cdc6, Cdt1 and Mcm2-7, in addition to a chromatin remodelling protein, nucleoplasmin, which is required for the initial binding of ORC to DNA 38 . Little is known about this reaction, but the available evidence indicates that ORC, Cdc6 and Cdt1 act together as a CLAMP LOADER to open the Mcm2-7 ring and load it around DNA 37 . Alternatively, the ORC, Cdc6 and Cdt1 molecules might facilitate the assembly of the Mcm2-7 hexamer from the many subcomplexes of MCM proteins that have been described. Consistent with these models, ORC, Cdc6 and Cdt1 are only required for the loading of Mcm2-7 onto DNA (licensing), but are not required for the continued association of Mcm2-7 on DNA once this has occurred [39] [40] [41] [42] . Both ORC and Cdc6 are ATPases, and the licensing reaction is dependent on hydrolysable ATP 38 . ATP hydrolysis might provide the energy that is required to break open the hexameric ring of Mcm2-7 to allow it to reform around DNA. Cdt1 can directly bind components of the Mcm2-7 hexamer [43] [44] [45] , and so the role of Cdt1 might be to recruit Mcm2-7 to the DNA. Cdc6 must already be bound to chromatin before Cdt1 can join the complex in an active form, consistent with Cdt1 having a role in recruiting Mcm2-7 to a clamp loader that comprises ORC and Cdc6 REF. 46. Geminin, an important inhibitor of the licensing system in metazoans (see below), binds tightly to Cdt1 REFS 47,48, potentially blocking its ability to bind Mcm2-7 REF. 49. As both ORC and the Mcm2-7 hexamer are asymmetric complexes, it is possible that the orientation of ORC on DNA determines the orientation in which Mcm2-7 is loaded onto DNA. If, as discussed above, initiation requires two back-to-back Mcm2-7 complexes, it might then be necessary to have two ORC-Cdc6-Cdt1 complexes in different orientations on the DNA to achieve this (FIG. 4d) . Alternatively, Mcm2-7 might be loaded as preformed double hexamers. The components of the pre-RC might also have functions other than supporting origin licensing. Several lines of evidence indicate that ORC has an important role in generating transcriptionally silent chromatin in a process that is independent of its role in DNA replication 50 . Several reports also indicate that Cdc6 is involved in the activation of checkpoint pathways in S phase or during the progression from G2 into mitosis 34, 51, 52 .
Regulation of the licensing system
To prevent replicated origins becoming re-licensed during S phase, it is important that the ability to license new replication origins is downregulated before entry into S phase. Because ORC, Cdc6 and Cdt1 are required for the loading of Mcm2-7 onto DNA, but are not required for the continued association of Mcm2-7 on DNA, downregulation of their activity at the end of G1 is an effective way of preventing the re-licensing of replicated DNA. . This indicated an intellectually satisfying model in which low CDK levels at the beginning of the cell cycle (in late mitosis and early G1) permit origin licensing, whereas rising CDK levels at the end of G1 both prevent further licensing and at the same time promote the initiation of replication 56 .
In yeasts, CDKs function redundantly to prevent the re-licensing of replicated DNA, targeting all the components of the licensing system 3, 4 (FIG 5a) . One of the main substrates of CDK regulation in S. cerevisiae is Cdc6 (or the S. pombe homologue Cdc18), which is targeted for degradation following phosphorylation by CDKs at the G1-S-phase transition [57] [58] [59] . Cdc6/Cdc18 levels are also regulated at the transcriptional level to give maximum expression in late mitosis and G1 REFS 3,4. Furthermore, the ability of ORC to support re-replication is directly inhibited by CDK phosphorylation 60, 61 . In both fission and budding yeast, CDKs are directly recruited to ORC that is bound to origin DNA, and this helps to maintain ORC in an inactive state during S phase and G2 REFS 62,63. CDKs can also bind directly to Cdc6, which might also contribute to the prevention of re-replication 64 . In S. pombe, Cdt1 levels peak in late mitosis and early G1 and might be controlled by CDK-dependent transcription and proteolysis in a manner similar to Cdc6/Cdc18. This is probably important in preventing re-replication of DNA, as the overexpression of Cdt1 enhances re-replication that is induced by overexpression of Cdc18/Cdc6 REF. 65. In S. cerevisiae, CDKs promote the nuclear export of Cdt1 and Mcm2-7 during S phase, G2 and early mitosis, thereby preventing them from gaining access to chromosomal DNA 66, 67 . Experiments in S. cerevisiae indicated that for significant re-replication to occur, all these different CDKdependent controls must be inactivated. Partial over-replication was only seen when unphosphorylatable mutants of orc2 and orc6 were combined with non-degradable Cdc6 and constitutively nuclear Mcm2-7 and Cdt1 REF. 60. These experiments indicate that, in yeasts, the direct inhibition of components of the licensing system by CDKs prevents the re-licensing of replicated DNA.
Regulation of licensing in metazoans.
There is evidence that CDK levels are also important for regulating the licensing system in metazoans 4 . For example, fluctuations of cyclin E levels are required to drive ENDOREDUPLICATION cycles in Drosophila melanogaster 68, 69 . However, the role of CDKs in inhibiting the licensing Transfer of one (mono-) or several (poly-) ubiquitin molecules onto a protein which typically targets it for proteasome-mediated proteolysis.
SCF
The largest family of ubiquitin protein ligases; each is typically composed of a SKP1 homologue, a cullin, an F-box protein and a RING-domain protein, which ubiquitylates proteins, thereby marking them for proteasome-mediated proteolysis.
SKP2
A component of an SCF ubiquitin protein ligase, which provides an adaptor that links the F-box protein to the cullin. system in metazoans is less clear-cut than it is in yeasts (FIG. 5b) , and it seems likely that CDK levels only indirectly affect the activity of the licensing system.
ORC from mammalian somatic cells is a labile complex. The ORC1 subunit is loosely associated with the ORC2, ORC3, ORC4, ORC5 subcomplex and is targeted for degradation in S phase by an SCFDEPENDENT POLYUBIQUITYLATION reaction that might depend on CDK activity [70] [71] [72] . Alternatively, in some cell lines, ORC1 seems to be stable in S phase but is mono-ubiquitylated and/or phosphorylated as S phase progresses 73, 74 . It has been suggested that this ORC1 cycle contributes to the regulation of the licensing system, but experimental evidence for this is still lacking. Unlike the situation in yeasts, metazoan Cdc6 seems to be bound to chromatin throughout much of the cell cycle, including G2 REFS 34,75,76. Excess Cdc6 is exported out of the nucleus during S phase as a consequence of CDK activity, but there is no evidence that this plays a part in preventing re-replication of DNA [77] [78] [79] [80] . Only in mitosis is there clear evidence in metazoans of a direct inhibitory effect of high CDK levels on the licensing system 47, 81 . Instead, the main route by which metazoans prevent licensing during S phase and G2 is by downregulation of Cdt1 activity. This is brought about both by degradation of the Cdt1 protein and by activation of a Cdt1 inhibitory protein called geminin. Cdt1 is degraded at the end of G1 and early S phase (FIG. 5b) in a process that depends on the activity of SCF-class ubiquitin ligases 48, [82] [83] [84] [85] [86] . In human cells, a SKP2-containing SCF interacts with CDT1, and is dependent on prior phosphorylation of CDT1 by CDK2 or CDK4 REFS 85,8789. CDK-dependent degradation of Cdt1 has also been observed in X. laevis 90 . There are, however, Skp2-independent pathways that can still degrade Cdt1, because mutants of Cdt1 that are not phosphorylated by CDK and that do not interact with Skp2 are still degraded normally at the onset of S phase 91 (D. Takeda and A.D., unpublished observations). In Caenorhabditis elegans, a related CUL4 UBIQUITIN LIGASE is required to downregulate CDT-1 levels at the end of G1 REF. 86. Loss of CUL-4 leads to CDT-1-dependent re-licensing and replication 86 . Similarly, the overexpression of Cdt1 in humans, D. melanogaster or X. laevis led to significant re-replication, an effect that was also enhanced by co-expression of Cdc6 REFS 79,9094. In X. laevis, the simultaneous loss of geminin and stabilisation of Cdt1 is sufficient to cause extensive re-licensing and re-replication 92 .
In addition to being degraded during S phase, Cdt1 is stabilized during G2 and M by binding to geminin, which seems to protect Cdt1 from ubiquitin-mediated degradation 81 . This stabilization by geminin allows Cdt1 levels to build up in an inactive form, ready for its function in late mitosis. If only geminin-bound Cdt1 is protected from degradation, this ensures that the quantity of Cdt1 will not exceed the amount that can be inhibited by geminin.
Geminin inhibits Cdt1 by binding to it, and it is the main inhibitor of licensing during S phase and G2 REFS 47, 48, 84, 95. Geminin activity is downregulated in late mitosis, either through proteolysis 95 or by posttranslational inactivation such as CDK-dependent ubiquitylation 84, 96 , and this allows activation of the licensing system as cells exit metaphase. At the end of G1, geminin is stabilized and/or re-activated, thereby preventing any further licensing. The importance of geminin in preventing re-replication is shown by the observation that the loss of geminin in D. melanogaster or human tissue culture cells leads to extensive re-replication of DNA 83, [97] [98] [99] . Geminin has been reported to be a regulator of transcription factors, and so misregulation of transcription could contribute to the rereplication 100, 101 . However, overexpression of Cdt1 can by itself stimulate re-replication, indicating that Cdt1 is the relevant target of geminin for the prevention of rereplication 79, [90] [91] [92] [93] [94] . Taken together, these results indicate that, in most metazoan cells, the main feature that prevents the re-licensing of replicated DNA is the absence of Cdt1 activity, which can occur despite any potential CDK-dependent inhibitory phosphorylation of ORC, Cdc6 and Mcm2-7 proteins.
Several structural studies have recently highlighted how geminin might inhibit Cdt1 function. Geminin forms an elongated dimer through the interaction of its COILEDCOIL DOMAINS 49, [102] [103] [104] . The crystal structure The activity of components of the licensing system during the cell cycle of yeasts (a) and metazoans (b) is shown. In the lower part of each figure, the licensing system is shown. This is active (green) only in G1. In yeasts, licensing is inhibited at other times by cyclin-dependent kinases (CDKs; blue), whereas in metazoans, licensing is inhibited in S phase and G2 by geminin (orange) and in mitosis by a combination of geminin and CDKs (purple). Above this, the activity of different pre-replicative complex components origin recognition complex (ORC), Cdc6, Cdt1 and minichromosome maintenance (Mcm)2-7 proteins is shown. Green indicates active proteins; red indicates inactive/degraded or exported proteins.
of the central region of Cdt1 complexed with a fragment of geminin has been solved 49 (FIG. 6) . One molecule of Cdt1 interacts asymmetrically with the geminin dimer, forming contacts between highly conserved amino acids in helix H1 and surface residues on the coiled-coil domain of both subunits of geminin. A second unstructured loop immediately N-terminal to the coiled-coil domain of geminin makes a second contact with Cdt1 that is essential for the inhibition of DNA replication. A structure-function study that was carried out with full length Cdt1 indicated that the N-terminal 160 residues of Cdt1 that were not present in the co-crystal also interact with the N-terminal unstructured loop of geminin 103 . Furthermore, an electron microscopic study indicated that geminin dimers might associate with each other to form tetramers 105 . These studies indicate that the geminin-Cdt1 interaction might interfere with Cdt1-Mcm2-7 interaction by steric hindrance and therefore interfere with the loading of Mcm2-7.
Checkpoint pathways and re-replication
When the licensing system is artificially misregulated to allow cells to inappropriately re-relicense their DNA, re-replication of DNA is observed 60, 79, 92, [97] [98] [99] . This indicates that replication licensing is the main system that prevents the re-replication of DNA in a single cell cycle. However, when re-replication occurs, various CHECK POINT pathways are activated. Checkpoint kinaseswhich comprise the upstream ATM and ATR kinases and the Chk1 and Chk2 downstream kinases -are typically activated when DNA is damaged or if problems are detected during progression through the cell cycle. Although the precise mechanism is not understood, it is probable that checkpoint activation in response to misregulation of the licensing system is a consequence of a structural problem that occurs during re-replication (such as a replication fork running into the back of another fork), rather than owing to re-licensing itself 106 . Overexpression of Cdt1 or depletion of geminin (which induces re-replication) activates ATM/ATRChk1/Chk2-dependent checkpoint pathways that lead to an arrest of the cell cycle and/or apoptosis 79, 92, [97] [98] [99] . Cells that overexpress Cdt1 and Cdc6 use p53 as the main effector downstream of the ATM/ATR checkpoint kinases, whereas cells that are depleted of geminin use the checkpoint kinase Chk1 as the main effector. The reason for this differential use of effectors is unclear, but could indicate a role for either Cdc6 or
Box 2 | Cyclin-dependent kinases
Cyclin-dependent kinases (CDKs) are the master drivers of cell-cycle progression. They consist of a small protein kinase subunit that is inactive unless complexed with a larger cyclin partner. CDK activity is low or absent during most of G1, but is high throughout late G1, S phase, G2 and mitosis. Among the cell-cycle transitions that are dependent on CDK activity is the transcriptional programme that occurs in late G1 and that commits cells to divide, progress into and through S phase, and progress into and through mitosis. Several cyclins and kinase subunits can drive these different transitions. In metazoans, cyclin D-Cdk4/6 and cyclin E-Cdk2 play an important part in activating transcription during late G1, whereas cyclin E-Cdk2 and cyclin A-Cdk2 play an important part in promoting the initiation of DNA replication. In most cases, the abundance of the kinase subunit remains constant whereas the abundance of the cyclin partner varies throughout the cell cycle. An important component of this control is the cell cycle regulated degradation of cyclins, which is mediated by ubiquitin-dependent proteolysis. In metazoans, for example, A-type cyclins are degraded during metaphase whereas B-type cyclins are degraded during anaphase. CDK activity is also controlled in other ways. The kinase subunit is subject to both inhibitory and activating phosphorylation. A range of CDK inhibitors also have an important role in regulating CDK activity during the cell cycle. In understanding the regulation of DNA replication by CDKs, it should be noted that origin licensing typically occurs in G1 when CDK activity is low, whereas the initiation of replication forks is dependent on CDK activity. A family of transcription factors that plays an important part in regulating the transcription of key cell cycle genes in late G1 and S phase.
RB FAMILY
The retinoblastoma family, which includes the Rb protein itself and the related p107 and p130 proteins, which bind the E2F family of transcription factors and repress transcription.
geminin in determining how the checkpoint kinases are directed to their substrates 34 . Consistent with this idea, Cdc6 has been reported to be involved in checkpoint activation independent of it its role in licensing 34, 51, 52, 99 . The activation of p53 leads to apoptosis in addition to cell-cycle arrest. The cells also undergo apoptosis (but in a p53-independent reaction) if the Chk1-dependent G2 arrest that follows geminin depletion is over-ridden. Therefore, metazoans are spared the ill consequences of re-replication by at least two back-up pathways: checkpoint-induced cell-cycle inhibition and/or apoptosis.
In addition to being degraded during S phase, Cdt1 is also degraded in response to DNA damaging agents. Treatment of human or D. melanogaster tissue culture cells with ionising radiation led to an almost complete loss of CDT1 protein 107 . This CDT1 degradation occurred in cells during G1 and depended on the CUL4 ubiquitin ligase, but not on ATR-or ATMdependent checkpoint pathways. Human tissue culture cells treated with ultraviolet (UV) radiation also undergo CDT1 degradation 108 . In contrast to the findings from studies using ionising radiation, the sensitivity of UV-induced Cdt1 degradation to various checkpoint-kinase inhibitors indicated that ATR kinase activity is involved. These results indicate that downregulation of the licensing system is an additional route by which cells can prevent DNA replication in the face of DNA damage.
Coordination of licensing and proliferation
When cells withdraw from the cell cycle, either temporarily into G0 QUIESCENCE, or permanently as a consequence of terminal differentiation or SENESCENCE, Cdc6, Cdt1 and Mcm2-7 are downregulated and degraded, leaving only ORC at the origins (reviewed in REF. 3) (FIG. 7) . At first, it seems surprising that unreplicated DNA becomes unlicensed on exit from the cell cycle. One possibility is that this provides a barrier to prevent non-proliferating cells from re-entering the cell division cycle. Indeed, an early change that is seen in premalignant lesions is the presence of Mcm2-7 in cells which do not normally express these proteins 109 . As the loss of the licensed state represents a crucial change to the replicative potential of the cell as it exits from G1 into G0, it provides an attractive functional definition of exit from the proliferative state 3, 110 . The transcription of CDC6, CDT1 and MCM2-7 all seem to be responsive to the E2F FAMILY of transcription factors that are activated on exit from G0 REFS 111113. E2F-driven transcription is normally repressed by members of the RB FAMILY, which are in turn repressed by CDK-dependent phosphorylation (primarily by cyclin E-Cdk2 and cyclin D-Cdk4/6). Cyclin-E knockout embryos (cyclin E1 -/-cyclin E2 -/-) show almost normal proliferation and developmental capacity. However, they fail to make trophoblast giant cells and megakaryocytes, which are both cell types that need to endoreduplicate to attain a >2N DNA content 114, 115 . Mouse embryo fibroblasts (MEFs) derived from the cyclin-E knockout embryos were unable to re-enter S phase after being driven into G0 by serum starvation or contact inhibition. In particular, these quiescent cyclin-E knockout cells failed to load MCM2 onto chromatin despite the normal loading of ORC and CDC6 REFS 114,115. These studies indicate that, whereas cyclin E is dispensable for licensing to occur after exit from normal mitosis, it is essential for licensing at other times -either on exit from G0 or during endoreduplication cycles. Consistent with this idea, work in D. melanogaster has also indicated a requirement for Cyclin E in MCM2-7 loading during endoreduplication cycles 68, 69, 116 . The picture is further complicated by the observation that Cdk2 knockout mice -which lack the only known kinase partner of cyclin E -are viable, and produce MEFs that can exit normally from serum starvation 117, 118 . Although the precise role of CDKs in activating the licensing system is unclear, it is possible that during normal cell-cycle progress, a range of CDKs (including cyclin B-Cdk1; REF. 96) have redundant roles in activating the licensing system. On exit from G0, fewer CDKs might be available -whereas cyclin A-Cdk1 might replace cyclin E-Cdk2 in Cdk2 knockout cells, cyclin A-Cdk2 might not do so in cyclin-E knockout cells 115 .
What is the essential role of cyclin E in licensing during exit from G0? One possibility is that cyclin E is required for the synthesis of Cdt1 (ORC and CDC6 levels were normal in the cyclin E -/-MEFs). Another possibility is that cyclin E is directly or indirectly required for the activation of one of the pre-RC components when cells exit from G0. Consistent with this Geminin is activated in late G1, just prior to entry into S phase. From G1, cells also have the option of entering quiescence (the G0 state). On entry into G0 from G1, the DNA is delicensed and Mcm2-7, Cdc6 and Cdt1 are degraded. This might provide a barrier that prevents the inappropriate proliferation of these cells. On exit from G0 into S phase, quiescent cells must re-license their DNA, and cyclin E is required for this re-licensing. Cyclin E might be required to drive the re-synthesis or activation of Mcm2-7, Cdc6 or Cdt1, or it might be required to temporarily suppress geminin activity, which is also resynthesized prior to entry into S phase.
suggestion, an in vitro system that supports the replication of nuclei isolated from cells exiting from G0 shows a requirement for cyclin E in loading Mcm2-7 proteins onto chromatin 119 . One step that might require CDK activity is the inactivation of geminin. On exit from metaphase in X. laevis egg extracts, geminin is inactivated as a consequence of CDK-dependent ubiquitylation 96 . An analogous reaction that requires cyclin E for the inactivation of geminin could be postulated on exit from G0. However, geminin expression is also low in quiescent cells 120, 121 , and this explanation would require geminin levels to rise prior to the completion of licensing when cells re-enter the cell cycle (FIG. 7) , a point that has so far not been studied.
As licensing must be complete before cells enter S phase, it is plausible that cells possess a 'licensing checkpoint' that blocks entry into S phase until licensing is complete. In support of this idea, primary cells that overexpressed constitutively active geminin arrested in a G1-like state with hypophosphorylated Rb and with no evidence of attempts to initiate DNA replication 122, 123 . By contrast, various cancer-derived cell lines progressed into an unsuccessful S phase and ultimately underwent apoptosis. The nature of the licensing checkpoint that is seen in primary cells is currently unclear, but might provide a useful route by which to induce cancer-specific cell killing.
Conclusions and perspectives
Over the past few years, the basic mechanisms that ensure once-per-cycle replication of chromosomal DNA have been elucidated. Although the regulation seems to differ between yeasts and metazoans, in both groups it focuses on restricting the rebinding of Mcm2-7 to replicated DNA, therefore conforming to the original licensing factor hypothesis. In yeasts, the re-licensing of replicated DNA is prevented by high CDK activity, which represses different pre-RC components late in the cell cycle. By contrast, metazoans prevent the re-licensing of replicated DNA largely by inhibiting Cdt1 activity, which, in turn, may largely be due to the presence of active geminin. With the understanding of these basic pathways in place, it is now the time to address a number of further questions. It will be of great interest to understand the biochemical events that take place when Mcm2-7 are loaded onto DNA. Are Mcm2-7 loaded as hexamers or as double hexamers? Are there any features in the DNA sequence or chromatin that direct ORC to specific sites on the chromosomes? What is the relationship between the sites where ORC is bound, the sites where Mcm2-7 is bound and the sites where replication forks initiate? The answers to these questions might also shed light on the 'MCM paradox' -why there is such an excess of Mcm2-7 over replication origins. It will also be of great interest to understand how the licensing system is regulated when cells enter and exit quiescence. What roles do CDKs have in reactivating the licensing system on exit from quiescence? Are there checkpoint or feedback systems that monitor the success of this process? Is the unlicensed state of quiescent cells important for preventing illegitimate re-entry into the cell cycle? Do cancer cells acquire errors in these checkpoint and feedback pathways, and do such errors lead to genomic instability? Answering these and other questions will help to integrate our knowledge of cell-cycle control with the biophysical events that take place during the process of DNA replication and with the genomic instability that is the hallmark of many cancers.
